mdxhealth · 3 weeks ago
Supervisor, Customer Services
Mdxhealth is building a world class healthcare company, providing significant career development and financial opportunities. The Customer Service Supervisor is responsible for the efficient day-to-day operations of the Customer Services department, including providing guidance to staff, ensuring proper training, and maintaining quality metrics.
BiotechnologyHealth DiagnosticsMedical Device
Responsibilities
Responsible for the efficient day-to-day operations of the Customer Services department including providing work direction, expertise, and guidance to the staff
Ensures proper training and employee competencies are performed and submitted according to the deadlines
Conducts department meetings, and individual meetings with all staff to address corrective actions, employee concerns, suggestions, client issues, and process improvements
Assists the Customer Service Director in maintaining and improving the department’s quality metrics
Responsible for maintaining and revising the department Standard Operation Procedures
Manages, reviews, and approves employee timecards and time off requests
This role is also responsible for supporting and resolving elevated situations which cannot be resolved by Customer Service Specialist I, II, III, or Lead
Qualification
Required
Minimum of 6 years previous customer service experience
High level of accuracy and attention to detail
Ability to adapt to changing procedures, policies, and work environment
Ability to work in a fast-paced team environment
Preferred
Minimum 5 years in healthcare or a clinical reference laboratory a plus
In-depth understanding of clinical data and ability to convey sales & marketing messages
Benefits
Company paid medical, dental, vision and life insurance coverage
401(k) with company match
Generous employee discounts
A casual, but driven work environment
The ability to make a real difference as a key contributor to our growth
Company
mdxhealth
MDxHealth is a molecular diagnostics company that develops epigenetic tests for cancer assessment and personalized treatment of patients.
Funding
Current Stage
Public CompanyTotal Funding
$169.38MKey Investors
Innovatus Capital PartnersMVM Life Science PartnersKreos Capital
2024-09-25Post Ipo Equity· $40M
2023-02-03Post Ipo Equity· $37M
2022-08-02Post Ipo Debt· $35M
Recent News
2026-01-13
Company data provided by crunchbase